[vc_row][vc_column width="1/4"][vc_single_image image="19293" img_size="medium" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]Brain cancer is a formidable adversary in the world of oncology. Against substantial odds, patients work with dedicated doctors to mount a counteroffensive. The road to recovery is, to no one’s astonishment, arduous, as brain surgery exposes the very epicenter...
The effectiveness of certain chemotherapy drugs may be reduced by fat cells. This groundbreaking recent discovery was made according to a recent study published in November 2017 in Molecular Cancer Research, a journal of the American Association for Cancer Research. Obesity has long been associated with...
The mental status of cancer survivors can be fragile and destabilized. Psycho-social complications often arise, such as fear of recurrent illness, financial hardship, anxiety, difficulty handling the end of treatment, fatigue, lasting “brain fog”, broken relationships and even post-traumatic stress disorder. In order to navigate...
It is estimated that by the year 2030, deaths due to cancer will drop dramatically and life expectancy after diagnosis will have significantly increased. Whereas this is encouraging news and proof positive that the practice of oncology and the drugs used to treat cancer have...
[vc_row][vc_column][vc_single_image image="67628" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Researchers have found that the anti-tapeworm drug nitazoxanide (NTZ) may also offer hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters....
A new molecular discovery will allow doctors to select more effective treatment approaches based on the 9 subtypes of Renal Cell Carcinoma....
Search NFCR
Popular searches